HK Stock Market Move | YIDU TECH (02158) up more than 5%, wins bid for SMR001 Eye Drops Phase III Clinical Research Project.

YIDU TECH (02158) rose by more than 5%, as of the press release, it went up by 5.39%, reaching HK$6.06, with a turnover of HK$74.9734 million. On the news front, YIDU TECH announced that its affiliated company, Tianjin Happy Life Technology Co., Ltd., recently won the bid for the Phase III clinical research project of recombinant human nerve growth factor eye drops (SMR001) of Shandong Yandu Biotechnology Co., Ltd. The total amount of the project is approximately RMB 55.82 million. As a driver of the healthcare reform in China, YIDU TECH has built a closed-loop system of "Data-Algorithms-Scenarios" based on its independently developed core algorithm engine YiduCore, enabling efficient innovation of AI technology, low-cost scalability, and empowering intelligent decision-making for the entire healthcare industry chain.